Delaware · House Bill 383 · 152nd General Assembly

340B Drug Distribution/Prohibit Discrimination

HB 383 Sponsored by Kerri Evelyn Harris Withdrawn

  1. Introduced May 2, 2024
  2. In committee May 2, 2024
  3. Withdrawn  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

Section 1 of this Act prohibits discrimination against 340B drug distribution by manufacturers, repackagers, third-party logistics providers, and wholesalers. Violations are deemed an unlawful practice enforceable by the Consumer Protection Unit of the Department of Justice. The Department of Justice has authority to promulgate regulations under this section. The Board of Pharmacy may take disciplinary action…

Read the full title (168 words)

Section 1 of this Act prohibits discrimination against 340B drug distribution by manufacturers, repackagers, third-party logistics providers, and wholesalers. Violations are deemed an unlawful practice enforceable by the Consumer Protection Unit of the Department of Justice. The Department of Justice has authority to promulgate regulations under this section. The Board of Pharmacy may take disciplinary action against licensees based on the outcome of investigations or proceedings brought by the Department of Justice. Section 2 of this Act prohibits discrimination by pharmacy benefits managers against 340B covered entities. Violations are deemed unfair practices in the insurance business. Contracts purporting to include provisions in violation of this Act are deemed void and unenforceable. Section 3 of this Act contains severability language in the event that any provision or the application of the Act to a person or circumstance is deemed to be invalid. Section 4 of this Act contains non-preemption language to ensure that the Act can be read and interpreted to not conflict with other State or federal law.

Every action

15 steps, oldest first, as the legislature records them.

Show the 7 earlier steps
  1. CommitteeIntroduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House · House Economic Development/Banking/Insurance & Commerce
  2. CommitteeReported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 6 On Its Merits, 1 Unfavorable · House Economic Development/Banking/Insurance & Commerce
  3. HouseSubstituted in House by HS 1 for HB 383
  4. HouseSubstituted in House by HS 1 for HB 383
  5. HouseSubstituted in House by HS 1 for HB 383
  6. HouseHS 1 for HB 383 - - Passed In House by Voice Vote
  7. HouseHS 1 for HB 383 - - Passed In House by Voice Vote
  1. HouseHS 1 for HB 383 - Passed By House. Votes: 37 YES 1 NO 3 ABSENT
  2. SenateHS 1 for HB 383 - Assigned to Banking, Business, Insurance & Technology Committee in Senate
  3. HouseSubstituted in House by HS 1 for HB 383
  4. SenateHS 1 for HB 383 - Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 6 On Its Merits
  5. SenateHS 1 for HB 383 - - Passed By Senate. Votes: 21 YES
  6. SenateHS 1 for HB 383 - Passed By Senate. Votes: 21 YES
  7. HouseHS 1 for HB 383 - Passed By House. Votes: 40 YES 1 ABSENT
  8. HS 1 for HB 383 - Signed by Governor

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it, joined by 10 cosponsors: 10 Democrats.

All 10 cosponsors

From Delaware's official records (legis.delaware.gov), checked Nov 1, 2026. Text links go to the official versions; LegiList does not copy bill text.